Intra-Cellular Therapies Inc to Feature Highlights of Several of its Development Programs Transcript
Good afternoon, and welcome to Intra-Cellular Therapies Virtual Event, which will feature presentations on the company's pipeline, including lumateperone, ITI-1284, the PDE1 inhibitor platform and ITI-333. There will be 2 question-and-answer sessions during today's program. Questions can be submitted throughout the presentations. (Operator Instructions)
I will now turn this call over to Dr. Mates.
Thank you, operator. Good afternoon, everyone. I'm Dr. Sharon Mates, Chairman and CEO of Intra-Cellular Therapies. In today's virtual event, we will be sharing highlights of our development programs.
Joining me today from Intra-Cellular Therapies are Dr. Suresh Durgam, our Chief Medical Officer; and Dr. Robert Davis, our Chief Scientific Officer. They lead our clinical development and research efforts.
Dr. Durgam is a psychiatrist with nearly 25 years of clinical research experience in neuropsychiatric drug development. He has led clinical programs and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
